Study of INBRX-109 in Conventional Chondrosarcoma

计划入组 206 人 · 首次发布于 2021 年 7 月 6 日

A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma

计划入组 105 人 · 首次发布于 2011 年 3 月 9 日

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

计划入组 136 人 · 首次发布于 2023 年 11 月 13 日

Pegloticase(Krystexxa)

Filgotinib(Jyseleca)

C₂₁H₂₃N₅O₃S

Chymotrypsin

Rx

Aroa Biosurgery Ltd

Canada

Immuneering

United States

Avenue Therapeutics

United States

Inhibrx Reports Positive Phase 1/2 Data for Ozekibart in Colorectal Cancer, Plans FDA Filing for Chondrosarcoma

Inhibrx to Present Topline Results from Registrational Chondrosarcoma Trial of Ozekibart

Inhibrx Advances Ozekibart Toward FDA Decision as PFS Data in HNSCC Looms